Article ; Online: Evidence-based prescribing of medications for ADHD: where are we in 2023?
Expert opinion on pharmacotherapy
2023 Volume 24, Issue 4, Page(s) 425–434
Abstract: Introduction: A large number of randomized controlled trials (RCTs) and observational studies on the pharmacotherapy of ADHD are available.: Areas covered: Based on a search in PubMed and PsycInfo (up to 15 September 2022), this review addresses to ... ...
Abstract | Introduction: A large number of randomized controlled trials (RCTs) and observational studies on the pharmacotherapy of ADHD are available. Areas covered: Based on a search in PubMed and PsycInfo (up to 15 September 2022), this review addresses to which extent this body of research is currently able to inform routine prescribing practice, in terms of the choice of medication, titration strategy, augmentation treatments, and use of alternative, non-approved treatments. Expert opinion: A growing body of evidence is informing prescribers on some, but certainly not all, aspects related to the pharmacological treatment of ADHD in the daily clinical practice, with important weaknesses/gaps that need to be addressed. First, evidence synthesis of RCTs is not able to inform decision-making at the individual patient level. Second, the maximum safe and effective doses, possibly beyond those currently recommended, are not well understood. Third, evidence from RCTs on augmenting strategies is still limited. Fourth, no novel agents with the same or higher effect size of stimulants, in terms of efficacy, but with better tolerability and lower abuse potential, have been found. Implementation of precision psychiatry approaches and stratification of patients in future RCTs will be key to, respectively, individualize the treatment strategies and test etiopathophysiology-based agents. |
---|---|
MeSH term(s) | Humans ; Attention Deficit Disorder with Hyperactivity/drug therapy ; Central Nervous System Stimulants/adverse effects |
Chemical Substances | Central Nervous System Stimulants |
Language | English |
Publishing date | 2023-01-21 |
Publishing country | England |
Document type | Review ; Journal Article |
ZDB-ID | 2001535-5 |
ISSN | 1744-7666 ; 1465-6566 |
ISSN (online) | 1744-7666 |
ISSN | 1465-6566 |
DOI | 10.1080/14656566.2023.2169604 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5130: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.